Company profileNutraceutical & supplements#252 of 1,318 in Pakistan10 DRAP alerts

FOCOUS & RULZ PHARMACEUTICALS

Nutraceutical & supplement manufacturer · 72 registered products

Ranked #40 of 62 companies in Drugs For Obstructive Airway Diseases, Systemic

72 registered products 35 distinct molecules 10 DRAP alerts

72 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

registered products

distinct molecules

therapeutic classes

DRAP alerts

FOCOUS & RULZ PHARMACEUTICALS is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 72 product registrations. Its portfolio is concentrated in Drugs For Obstructive Airway Diseases, Systemic and Antidiarrheals, Intestinal Antiinflammatory/Antiinfective. DRAP has issued 364 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by FOCOUS

51 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Other Beta-Lactam, Cephalosporins & Penems 10

Ruzoneceiling Rs 584.84 Ruzone500mgceiling Rs 299.14 Ruzone250mgceiling Rs 177.72 Ruzone1gceiling Rs 584.84 Trag250mgceiling Rs 100.5 Trag500mgceiling Rs 151.47 Tragceiling Rs 272.42 Trag1gceiling Rs 272.42 Vfix400mgceiling Rs 536.59 Vfix200mgceiling Rs 290.33

Quinolone Antibacterials 5

Ciprulz250mgceiling Rs 236.85 Ciprulz500mgceiling Rs 391.71 Ciprulz125mgceiling Rs 211.89 Woff500mgceiling Rs 757.93 Woff250mgceiling Rs 455.48

Macrolides, Lincosamides And Streptogramins 3

Clarolid125mgceiling Rs 406.29 Clarolid250mgceiling Rs 422.32 Clarolid500mgceiling Rs 703.86

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 3

Helezol20MgRs 126.91 Helezol40MgRs 432.74 Omper20mgceiling Rs 262.36

Calcium Channel Blockers 2

Neopres10mgRs 98.3 Neopres5mgRs 52.3

Antivirals For Systemic Use 1

Tenv300mgceiling Rs 6,285.72

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

ceilings with an approval date

not revised in 2+ years

2025

oldest approval year

202551

Top molecules by brand count

Nutritional Supplement / Multivitamin53 brands

Mebeverine2 brands

Fluvoxamine1 brand

Montelukast1 brand

Levetiracetam ...... 500 Mg1 brand

Levetiracetam ...... 1000 Mg1 brand

Levetiracetam1 brand

Betahistine1 brand

Lactulose1 brand

Zinc1 brand

Therapeutic classes

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official6 products · Rs 90.89 – Rs 4,581.73

Median across source: Rs 148.44

Regulatory record

10 alerts in the DRAP feed we track.

39. Rapid Alert . SPURIOUS AND UNREGISTERED ONCOLOGY PRODUCTS

2026-07-29

38. Rapid Alert – Falsified JAKAVI® (Ruxolitinib) Tablets

2026-07-16

37. Rapid Alert – Falsified DARZALEX (Daratumumab) Injection

2026-07-16

36. Recall Alert – Medical Devices Declared Substandard by CDL Karachi

2026-07-14

35. Recall Alert – DTL Punjab Declared Substandard Drug Products.

2026-06-18

34- Recall Alert- DTL Sindh declared Substandard Auto Disable Syringes

2026-06-08

33. Rapid Alert – SPURIOUS DRUG PRODUCTS (NOVIDAT 500MG Tablets and TONOFLEX-P Tablets)

2026-06-03

32. Rapid Alert – SPURIOUS / FALSIFIED DANZEN DS TABLETS

2026-06-02

Competitive set

Companies whose registered portfolio overlaps most with this one.

NABIQASIM INDUSTRIES (PVT) LTD.18 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.17 shared molecules

SEARLE PAKISTAN (PVT.) LTD.17 shared molecules

Wilshire Laboratories (Private) Limited16 shared molecules

Genix Pharma Private Limited15 shared molecules

HILTON PHARMA (PVT) LIMITED15 shared molecules

VALOR PHARMACEUTICALS14 shared molecules

GLOBAL BRANDS DISTRIBUTORS13 shared molecules

GETZ PHARMA PAKISTAN (PVT) LTD.13 shared molecules

EFROZE CHEMICAL INDUSTRIES (PVT) LTD.12 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 171 molecules not in this portfolio

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 136 molecules not in this portfolio

SEARLE PAKISTAN (PVT.) LTD. holds 209 molecules not in this portfolio

Get the full profile for FOCOUS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included